Ajanta Pharma has reported results for third quarter ended December 31, 2015.
The company has reported 21.99% rise in its net profit at Rs 103.34 crore for the quarter ended December 31, 2015 as compared to Rs 84.71 crore for the same quarter in the previous year. The company’s total income has increased by 15.02% to Rs 424.23 crore for the quarter under review from Rs 368.84 crore for the corresponding quarter of the previous year.
On the consolidated basis, the company has reported 19.60% rise in its net profit after taxes, minority interest and share of profit / (loss) of associates of Rs 111.30 crore for the quarter ended December 31, 2015 as compared to Rs 93.06 crore for the same quarter in the previous year. Total income of the company has increased by 15.03% at Rs 474.38 crore for quarter under review as compared to Rs 412.39 crore for the quarter ended December 31, 2014.